/CME
CME Stock - CME Group Inc.
Financial Services|Financial - Data & Stock ExchangesNASDAQ
$269.09+1.15%
+$3.06 (+1.15%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.47
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).73
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+11.3%upside
Target: $299.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CME
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$266.40 – $271.78
TARGET (TP)$299.57
STOP LOSS$247.56
RISK/REWARD1:1.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.29
52W High$290.79
52W Low$224.62
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.13B | $5.58B | $5.02B | $4.69B | $4.88B |
| Gross Profit | $5.28B | $4.75B | $4.27B | $3.85B | $4.03B |
| Gross Margin | 86.1% | 85.1% | 85.0% | 82.2% | 82.5% |
| Operating Income | $3.93B | $3.44B | $3.02B | $2.65B | $2.64B |
| Net Income | $3.53B | $3.23B | $2.69B | $2.64B | $2.11B |
| Net Margin | 57.5% | 57.8% | 53.6% | 56.2% | 43.1% |
| EPS | $9.69 | $8.87 | $7.41 | $7.30 | $5.88 |
Company Overview
CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
7
41%
Hold / Neutral
7
41%
Sell / Underperform
3
18%
Analyst Consensus🔴 Bearish
7 Bullish10 Neutral/Bearish
Price Targets
$232
Average Target
↓ 13.6% Downside
Now
$171
Low
$232
Average
$305
High
Based on 22 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 23rd 2025 | Deutsche Bank | Upgrade | Buy | $300 |
| September 25th 2025 | Citigroup | Upgrade | Buy | $300 |
| July 24th 2025 | UBS | Downgrade | Neutral | $305 |
| April 8th 2025 | Morgan Stanley | Upgrade | Overweight | $301 |
| March 10th 2025 | Raymond James | Upgrade | Outperform | $287 |
| January 6th 2025 | Citigroup | Downgrade | Neutral | $250← $255 |
| October 8th 2024 | Redburn Atlantic | Downgrade | Neutral | $244 |
| September 27th 2024 | RBC Capital Mkts | Initiation | Sector Perform | $235 |
| September 26th 2024 | TD Cowen | Initiation | Hold | $221 |
| September 3rd 2024 | BofA Securities | Downgrade | Underperform | $177← $212 |
| June 21st 2024 | JP Morgan | Downgrade | Underweight | $187← $206 |
| January 8th 2024 | Barclays | Downgrade | Equal Weight | $222← $244 |
| January 3rd 2024 | Goldman | Downgrade | Sell | $195 |
| September 6th 2023 | BofA Securities | Upgrade | Neutral | $204← $167 |
| June 28th 2023 | Barclays | Initiation | Overweight | $215 |
Earnings History & Surprises
CMEBeat Rate
94%
Last 18 quarters
Avg Surprise
+2.2%
EPS vs Estimate
Beats / Misses
17/0
1 met exactly
Latest EPS
$2.68
Q4 2025
EPS Surprise History
Q1 24
+3.9%
$2.37vs$2.28
Q2 24
+2.0%
$2.50vs$2.45
Q3 24
+1.2%
$2.56vs$2.53
Q4 24
+0.8%
$2.68vs$2.66
Q1 25
+2.4%
$2.52vs$2.46
Q2 25
0.0%
$2.80vs$2.80
Q3 25
+1.7%
$2.96vs$2.91
Q4 25
+1.9%
$2.68vs$2.63
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 21, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $2.69 | — | — | — |
Q4 2025 | Oct 22, 2025 | $2.63 | $2.68 | +1.9% | ✓ BEAT |
Q3 2025 | Jul 23, 2025 | $2.91 | $2.96 | +1.7% | ✓ BEAT |
Q2 2025 | Apr 23, 2025 | $2.80 | $2.80 | 0.0% | = MET |
Q1 2025 | Feb 12, 2025 | $2.46 | $2.52 | +2.4% | ✓ BEAT |
Q4 2024 | Oct 23, 2024 | $2.66 | $2.68 | +0.8% | ✓ BEAT |
Q3 2024 | Jul 24, 2024 | $2.53 | $2.56 | +1.2% | ✓ BEAT |
Q2 2024 | Apr 24, 2024 | $2.45 | $2.50 | +2.0% | ✓ BEAT |
Q1 2024 | Feb 14, 2024 | $2.28 | $2.37 | +3.9% | ✓ BEAT |
Q4 2023 | Oct 25, 2023 | $2.22 | $2.25 | +1.4% | ✓ BEAT |
Q3 2023 | Jul 26, 2023 | $2.20 | $2.30 | +4.5% | ✓ BEAT |
Q2 2023 | Apr 26, 2023 | $2.38 | $2.42 | +1.7% | ✓ BEAT |
Q1 2023 | Feb 8, 2023 | $1.88 | $1.92 | +2.1% | ✓ BEAT |
Q4 2022 | Oct 26, 2022 | $1.94 | $1.98 | +2.1% | ✓ BEAT |
Q3 2022 | Jul 27, 2022 | $1.93 | $1.97 | +2.1% | ✓ BEAT |
Q2 2022 | Apr 27, 2022 | $2.00 | $2.11 | +5.5% | ✓ BEAT |
Q1 2022 | Feb 9, 2022 | $1.64 | $1.66 | +1.2% | ✓ BEAT |
Q4 2021 | Oct 27, 2021 | $1.55 | $1.60 | +3.2% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $1.61 | $1.64 | +1.9% | ✓ BEAT |
Latest News
Barclays Maintains Equal-Weight on CME Group, Raises Price Target to $304
📈 PositiveBenzinga•Dec 12, 2025, 08:11 PM•Also:
CME Group Announces SEC Approval For Registration Of New Securities Clearing House, CME Securities Clearing
📈 PositiveBenzinga•Dec 2, 2025, 03:03 PM
CME Group Reports Monthly Average Daily Volume Of 33.1M Contracts In November, Up 10% YoY
📈 PositiveBenzinga•Dec 2, 2025, 12:46 PM
'CME Data Center Bolsters Backup Cooling After 10-Hour Outage' - Bloomberg
➖ NeutralBenzinga•Dec 1, 2025, 08:00 AM
Piper Sandler Maintains Overweight on CME Group, Raises Price Target to $313
📈 PositiveBenzinga•Nov 13, 2025, 02:47 PM
FanDuel And CME Group To Launch "FanDuel Predicts" App, Bringing Prediction Markets On Sports And Economic Events To U.S. Users
📈 PositiveBenzinga•Nov 12, 2025, 09:44 PM•Also:
Watching CME Group; Hearing Investor Business Daily SwingTrader Buys Stock
📈 PositiveBenzinga•Nov 7, 2025, 06:46 PM
UBS Maintains Neutral on CME Group, Lowers Price Target to $280
➖ NeutralBenzinga•Oct 23, 2025, 09:34 PM•Also:
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $314
📈 PositiveBenzinga•Oct 23, 2025, 05:58 PM
Deutsche Bank Upgrades CME Group to Buy, Raises Price Target to $300
📈 PositiveBenzinga•Oct 23, 2025, 11:26 AM•Also:
CME Gr Q3 Adj. EPS $2.68 Beats $2.63 Estimate, Sales $1.538B Beat $1.531B Estimate
📈 PositiveBenzinga•Oct 22, 2025, 11:01 AM
CME Group Opens Middle East Hub In Dubai To Enhance Regional Access To Global Derivatives And Risk Management Solutions
📈 PositiveBenzinga•Oct 15, 2025, 05:12 AM
Raymond James Maintains Outperform on CME Group, Lowers Price Target to $307
➖ NeutralBenzinga•Oct 13, 2025, 05:07 PM
KKR Completes $3.1 Billion Acquisition Of OSTTRA From S&P Global And CME Group
📈 PositiveBenzinga•Oct 10, 2025, 11:04 AM•Also:
Barclays Maintains Equal-Weight on CME Group, Lowers Price Target to $280
➖ NeutralBenzinga•Oct 8, 2025, 03:17 PM•Also:
CME Group Announces That Its Cryptocurrency Futures And Options Will Be Available To Trade 24 Hours A Day, Seven Days A Week Beginning In Early 2026, Pending Regulatory Review
📈 PositiveBenzinga•Oct 2, 2025, 02:07 PM
CME Group Achieves Record Cryptocurrency Average Daily Volume Of 340,000 Contracts Worth $14.1B Notional In Q3 2025
📈 PositiveBenzinga•Oct 2, 2025, 11:36 AM
Morgan Stanley Maintains Overweight on CME Group, Raises Price Target to $312
📈 PositiveBenzinga•Oct 1, 2025, 04:19 PM
JP Morgan Maintains Underweight on CME Group, Raises Price Target to $252
➖ NeutralBenzinga•Sep 25, 2025, 12:39 PM•Also:
Citigroup Upgrades CME Group to Buy, Raises Price Target to $300
📈 PositiveBenzinga•Sep 25, 2025, 11:20 AM•Also:
Frequently Asked Questions about CME
What is CME's current stock price?
CME Group Inc. (CME) is currently trading at $269.09 per share. The stock has moved +1.15% today.
What is the analyst price target for CME?
The average analyst price target for CME is $299.57, based on 1 analyst.
What sector is CME Group Inc. in?
CME Group Inc. operates in the Financial Services sector, specifically within the Financial - Data & Stock Exchanges industry. The company is traded on the NASDAQ exchange.
What is CME's market cap?
CME Group Inc. has a market capitalization of $97.03 billion, making it a large-cap company.
Does CME pay dividends?
No, CME Group Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Financial Services SectorBAM
Brookfield Asset Management Ltd.
$52.19
Mkt Cap: $84.2B
BMO
Bank of Montreal
$129.72
Mkt Cap: $93.6B
BNS
The Bank of Nova Scotia
$72.54
Mkt Cap: $90.4B
COIN
Coinbase Global, Inc.
$245.12
Mkt Cap: $62.7B
IBN
ICICI Bank Limited
$29.92
Mkt Cap: $106.9B
ICE
Intercontinental Exchange, Inc.
$160.30
Mkt Cap: $91.9B
MCO
Moody's Corporation
$503.08
Mkt Cap: $90.4B
MFG
Mizuho Financial Group, Inc.
$7.31
Mkt Cap: $91.7B
MMC
Marsh & McLennan Companies, Inc.
$184.70
Mkt Cap: $90.9B
NDAQ
Nasdaq, Inc.
$95.36
Mkt Cap: $54.8B
Explore stocks similar to CME for comparison